百奥赛图-B涨超11%再创新高 公司就偶联物项目与育世博达成进一步合作
Zhi Tong Cai Jing·2026-01-13 03:30

Core Viewpoint - The stock of Baiaosaitu-B (02315) surged over 11% during trading, reaching a historical high of 44 HKD, and is currently up 7.29% at 42.38 HKD with a trading volume of 81.9068 million HKD [1] Group 1: Agreement Details - On January 9, Baiaosaitu announced a licensing agreement with Yushibo to systematically evaluate the BsADC projects through a structured assessment mechanism [1] - The agreement grants Yushibo an option for global exclusive licensing of two BsADC projects from Baiaosaitu [1] - Baiaosaitu is entitled to receive an upfront payment for the option, and upon Yushibo exercising the option, Baiaosaitu will receive additional payments including option exercise fees, development and regulatory milestone payments, commercialization milestone payments, and sales royalties [1]

Biocytogen Pharmaceuticals (Beijing)-百奥赛图-B涨超11%再创新高 公司就偶联物项目与育世博达成进一步合作 - Reportify